Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LS301 for tumor margin detection in breast cancer surgery
NCT02807597Phase 2Terminated
- Start
- Feb 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules, Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of ls301 in breast cancer. Started Feb 2020; status: terminated.
02
Drugs
ls301
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02807597.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02807597.